• SENSEX 82,188.99
    746.95 (+0.92%)
  • BANKNIFTY 56,578.40
    817.55 (+1.47%)
  • Cochin Shipyard
    2,547.25 2,977.10(%)
  • Azad Engineering
    1,561.00 1,128.40(%)
  • Garden Reach Sh.
    3,199.05 1,180.10(%)
  • HDFC Bank
    1,996.30 1,996.30(%)
  • Reliance Industr
    1,451.35 1,608.95(%)
  • Reliance Power
    63.13 63.39(%)
  • Natl. Aluminium
    190.90 263.10(%)
  • HFCL
    92.19 171.00(%)
  • Ramkrishna Forg.
    674.40 1,064.00(%)
  • Suzlon Energy
    66.10 46.00(%)
  • IDFC First Bank
    72.25 84.50(%)
  • Sika Interplant
    1,265.00 399.96(%)
  • Multi Comm. Exc.
    7,529.95 7,529.95(%)
  • St Bk of India
    816.45 898.80(%)
  • Mazagon Dock
    3,380.30 1,417.20(%)
  • Hindustan Zinc
    510.75 717.10(%)
  • ICICI Bank
    1,461.95 1,471.10(%)
  • REC Ltd
    417.30 653.90(%)
  • Eternal Ltd
    264.10 304.50(%)
  • Bharat Electron
    389.05 240.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alpa Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 27710.0
  • ISIN : INE385I01010
99.04 1 (1.42%)
  • As on 07 Jun 2025 (EOD)

  • Today’s Low

    97.01

  • Today’s High

    100.69

  • Open

    98.65

  • Perv Close

    97.65

  • 52W Low

    79.60

  • 52W High

    144.50

Key Indicators

  • P/E(TTM)

    10.61

  • Mar.Cap (₹Cr.)

    208.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    86.40

  • Debt-Equity Ratio

    1.42

  • AGM Date

    06-Jun-2025

  • EPS

    9.35

  • P/E Ratio

    10.61

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    208.39

  • RONW (%)

    11.71

  • ROCE (%)

    14.32

Score Board

  • Equity (₹ in Cr.)

    21.04

  • BV (₹)

    86.40

  • Sales( ₹ in Cr.)

    111.64

  • NP (in Cr.)

    19.68

  • NP Var(%)

    14.0

  • Div%

    0.0

  • CPS (₹)

    10.40

  • EPS (₹)

    9.40

  • Traded Value (₹ in Lakhs)

    208.76

  • 52 Week High

    144.50

  • 52 Week Low

    79.60

  • Price BSE

    99.0

  • Price NSE

    99.00

  • Market Capital( in Cr.)

    208.76

  • P/C Ratio

    9.50

  • P/E Ratio

    10.60

  • Price Vs.BV

    9.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 108.74 92.96 112.27 97.55 85.97 77.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 108.74 92.96 112.27 97.55 85.97 77.99
Other Income 14.87 9.41 10.79 4.41 2.97 5.07
Stock Adjustments 0.64 -1.27 -0.53 1.15 0.42 -1.53
Total Income 124.25 101.10 122.53 103.11 89.36 81.53
EXPENDITURE :            
Raw Materials 68.68 53.67 69.24 60.62 51.42 47.31
Power and Fuel Cost 3.02 3.04 2.64 2.43 2.21 2.01
Employee Cost 13.26 12.17 11.93 11.75 11.82 12.04
Other Manufacturing Expenses 3.62 3.69 3.69 2.86 2.07 2.25
Selling and Administration Expenses 8.64 7.42 8.29 7.56 8.79 8.19
Miscellaneous Expenses 4.02 3.62 5.25 5.79 6.64 3.44
Employee Benefit Expenses 13.26 12.17 11.93 11.75 11.82 12.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 101.24 83.60 101.04 91.00 82.94 75.25
Operating Profit 23.02 17.48 21.48 12.12 6.42 6.29
Interest 0.39 0.22 0.24 0.10 0.20 0.57
Gross Profit 22.63 17.26 21.24 12.02 6.22 5.72
Depreciation 1.95 1.33 1.66 1.23 1.14 1.10
Profit Before Tax 20.68 15.93 19.58 10.79 5.08 4.62
Current Tax 3.78 3.60 3.10 2.39 1.75 1.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 -0.29 2.35 1.14 -0.75 0.59
Reported Net Profit 16.78 12.62 14.13 7.26 4.08 2.95
Extraordinary Items -0.41 -0.01 6.38 2.10 -1.31 0.28
Adjusted Net Profit 17.19 12.63 7.75 5.16 5.39 2.67
Adjustment below Net Profit 0.08 0.85 0.00 0.03 0.03 -0.07
P & L Balance brought forward 69.11 55.64 41.51 34.23 30.13 27.24
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 85.97 69.11 55.64 41.52 34.23 30.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.97 6.00 6.71 3.45 1.94 1.40
Earnings Per Share(Adj)-Unit Curr 7.97 6.00 6.71 3.45 1.94 1.40
Book Value 76.98 68.97 62.56 55.85 52.39 50.44
Book Value(Adj)-Unit Curr 76.98 68.97 62.56 55.85 52.39 50.44

Shareholding Pattern

  • Promoter Group

    57.29%

  • Public Share Holding

    42.71%

  • Custodian

    0.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,055,010 57.29 12,055,010 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,055,010 57.29 12,055,010 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 84,072 0.40 84,072 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 84,072 0.40 84,072 3
2] Non Institution
Bodies Corporate 114,236 0.54 114,236 43
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 660,890 3.14 660,890 399
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,387,967 6.60 1,387,967 26
Individuals holding nominal share capital up to Rs. 1 lakh 6,463,836 30.72 6,458,636 18,069
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 274,519 1.30 274,519 321
Sub Total 8,901,448 42.31 8,896,248 18,858
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 70 0.00 70 1
Total Shares held by Custodians and against which Depository Receipts have been issued 70 0.00 70 1
Grand Total ( A + B + C ) 21,040,600 100.00 21,035,400 18,872

Company Background

Alpa Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alpa Laboratories Ltd
  • BSE Code : 27710.0
  • ISIN : INE385I01010

  • Incorporation Year

    1988

  • Registered Office

    33/2 Pigdamber
    A B Road Rau, Indore,
    Madhya Pradesh-453446

  • Telephone

    91-731-4294567

  • FAX

    91-731-4294444

  • Chairman

    Mahendra Singh Chawla

  • Managing Director

    Paresh Chawla

  • Company Secretary

    Srashti Chopra

  • Auditor

    Padliya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Alpa Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alpa Laboratorie 99.22 123.61 108.74 10.61 13.38
Abbott India 31,751.10 6,097.18 5,848.91 47.70 44.71
Astrazeneca Phar 9,791.90 1,330.33 1,295.53 211.49 33.26
P & G Health Ltd 5,550.45 1,166.89 1,151.26 36.68 39.76
Glaxosmi. Pharma 3,431.50 3,866.05 3,723.49 63.25 58.72
Cipla 1,503.75 17,645.00 16,574.34 23.55 20.10
Amrutanjan Healt 714.85 437.58 421.23 40.66 20.84
Guj. Themis Bio. 322.55 174.19 169.82 72.00 44.82
Fermenta Biotec. 321.90 315.24 307.09 14.01 4.10
Bliss GVS Pharma 136.50 638.96 605.46 20.84 11.19
Ambalal Sarabhai 35.88 11.70 3.81 33.22 1.92